Li HY - Search Results

1

On the status of β-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment.

Lu LJ, Gan L, Hu JB, Ran L, Cheng QF, Wang RJ, Jin LB, Ren GS, Li HY, Wu KN, Kong LQ. Lu LJ, et al. Among authors: li hy. Med Oncol. 2014 May;31(5):956. doi: 10.1007/s12032-014-0956-x. Epub 2014 Apr 12. Med Oncol. 2014. PMID: 24729160

2

[A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].

Li HY, Ren GS, Arnould N, Brettes JP. Li HY, et al. Zhonghua Wai Ke Za Zhi. 2007 Jul 1;45(13):874-6. Zhonghua Wai Ke Za Zhi. 2007. PMID: 17953828 Chinese.

3

[Effect of small interfering RNA targeting CXCR4 on breast cancer angiogenesis].

Li HY, Ren GS, Tan JX. Li HY, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2009 May;29(5):954-8. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19460719 Chinese.

4

[The effects of shRNA-CXCR4 on breast cancer cells migration and invasion].

Li HY, Ren GS, Tan JX. Li HY, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 May;40(3):393-7. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19626989 Chinese.

5

Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells.

Zheng K, Li HY, Su XL, Wang XY, Tian T, Li F, Ren GS. Zheng K, et al. Among authors: li f, li hy. J Exp Clin Cancer Res. 2010 Apr 11;29(1):31. doi: 10.1186/1756-9966-29-31. J Exp Clin Cancer Res. 2010. PMID: 20380740 Free PMC article.

6

HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.

Tan JX, Wang XY, Li HY, Su XL, Wang L, Ran L, Zheng K, Ren GS. Tan JX, et al. Among authors: li hy. Int J Cancer. 2011 Mar 15;128(6):1303-15. doi: 10.1002/ijc.25460. Int J Cancer. 2011. PMID: 20473947

7

Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis.

Tan JX, Wang XY, Su XL, Li HY, Shi Y, Wang L, Ren GS. Tan JX, et al. Among authors: li hy. PLoS One. 2011;6(7):e22836. doi: 10.1371/journal.pone.0022836. Epub 2011 Jul 28. PLoS One. 2011. Retraction in: PLoS One. 2022 Nov 7;17(11):e0277500. doi: 10.1371/journal.pone.0277500 PMID: 21829529 Free PMC article. Retracted.

8

Chemosensitization role of endocrine hormones in cancer chemotherapy.

Huang JB, Ji GY, Xing L, Wang ZW, Li HY, Ren GS, Wu KN, Kong LQ. Huang JB, et al. Among authors: li hy. Chin Med J (Engl). 2013 Jan;126(1):175-80. Chin Med J (Engl). 2013. PMID: 23286497 Review. No abstract available.

9

Neo-endocrinochemotherapy: a novel approach for enhancing chemotherapeutic efficacy in clinic?

Huang J, Ji G, Xing L, Li H, Wang Z, Ren G, Wu K, Kong L. Huang J, et al. Med Hypotheses. 2013 Apr;80(4):441-6. doi: 10.1016/j.mehy.2012.12.037. Epub 2013 Jan 31. Med Hypotheses. 2013. PMID: 23375412

10

Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.

Li F, Yin X, Luo X, Li HY, Su X, Wang XY, Chen L, Zheng K, Ren GS. Li F, et al. Among authors: li hy. Cell Signal. 2013 Jun;25(6):1413-22. doi: 10.1016/j.cellsig.2013.03.012. Epub 2013 Mar 22. Cell Signal. 2013. PMID: 23524337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,434 results

Search Page

Filters